Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Finasteride helps female-pattern hair loss.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Different staff in a dermatology clinic understand mostly their own tasks, not the full clinic process.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

JAK inhibitors offer new hope for treating severe alopecia areata.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.